11.1 Tranquilisation or asleep: 1. sedation |
9 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
11.1.1 high risk of bias |
2 |
193 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.78 [1.15, 2.75] |
11.1.2 unclear risk of bias |
3 |
134 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.07 [0.62, 1.83] |
11.1.3 low risk of bias |
4 |
260 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.30 [0.83, 2.03] |
11.2 Global state: 1. no improvement |
6 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
11.2.1 unclear risk of bias |
1 |
48 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.56 [0.32, 0.97] |
11.2.2 low risk of bias |
5 |
290 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.23 [0.98, 1.56] |
11.3 Adverse effects/events: 1. extrapyramidal symptoms |
8 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
11.3.1 high risk of bias |
1 |
153 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.15 [0.01, 2.90] |
11.3.2 unclear risk of bias |
2 |
77 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.09 [0.01, 0.65] |
11.3.3 low risk of bias |
5 |
302 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.18 [0.06, 0.60] |